Palsgrove D.N.; Brosnan-Cashman J.A.; Giannini C.; Raghunathan A.; Jentoft M.; Bettegowda C.; Gokden M.; Lin D.; Yuan M.; Lin M.-T.; Heaphy C.M.; Rodriguez F.J., Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association, «MODERN PATHOLOGY», 2018, 31, pp. 1787 - 1800 [articolo]
Kiyofuji S.; Perry A.; Graffeo C.S.; Giannini C.; Link M.J., The dangers of the “Head Down” position in patients with untreated pituitary macroadenomas: case series and review of literature, «PITUITARY», 2018, 21, pp. 231 - 237 [articolo]
Sahm F.; Reuss D.E.; Giannini C., WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours, «NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY», 2018, 44, pp. 163 - 171 [articolo]
Pekmezci M.; Rice T.; Molinaro A.M.; Walsh K.M.; Decker P.A.; Hansen H.; Sicotte H.; Kollmeyer T.M.; McCoy L.S.; Sarkar G.; Perry A.; Giannini C.; Tihan T.; Berger M.S.; Wiemels J.L.; Bracci P.M.; Eckel-Passow J.E.; Lachance D.H.; Clarke J.; Taylor J.W.; Luks T.; Wiencke J.K.; Jenkins R.B.; Wrensch M.R., Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT, «ACTA NEUROPATHOLOGICA», 2017, 133, pp. 1001 - 1016 [articolo]Open Access
Prasad, N. K.; Tubbs, R. S.; Amrami, K. K.; Dyck, P. J. B.; Mauermann, M. L.; Giannini, C.; De Divitiis, O.; Spinner, R. J., Can intraneural perineuriomas occur intradurally? An anatomic perspective, «NEUROSURGERY», 2017, 80, pp. 226 - 234 [articolo]
Korfel, A.; Schlegel, U.; Johnson, D. R.; Kaufmann, T. J.; Giannini, C.; Hirose, T., Case-based review: Primary central nervous system lymphoma, «NEURO ONCOLOGY PRACTICE», 2017, 4, pp. 46 - 59 [articolo]
Johnson, D. R.; Diehn, F. E.; Giannini, C.; Jenkins, R. B.; Jenkins, S. M.; Parney, I. F.; Kaufmann, T. J., Genetically defined oligodendroglioma is characterized by indistinct tumor borders at MRI, «AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY», 2017, 38, pp. 678 - 684 [articolo]
Shankar, G. M.; Abedalthagafi, M.; Vaubel, R. A.; Merrill, P. H.; Nayyar, N.; Gill, C. M.; Brewster, R.; Bi, W. L.; Agarwalla, P. K.; Thorner, A. R.; Reardon, D. A.; Al-Mefty, O.; Wen, P. Y.; Alexander, B. M.; Van Hummelen, P.; Batchelor, T. T.; Ligon, K. L.; Ligon, A. H.; Meyerson, M.; Dunn, I. F.; Beroukhim, R.; Louis, D. N.; Perry, A.; Carter, S. L.; Giannini, C.; Curry, W. T.; Cahill, D. P.; Barker, F. G.; Brastianos, P. K.; Santagata, S., Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas, «NEURO-ONCOLOGY», 2017, 19, pp. 535 - 545 [articolo]
Cavalli F.M.G.; Remke M.; Rampasek L.; Peacock J.; Shih D.J.H.; Luu B.; Garzia L.; Torchia J.; Nor C.; Morrissy A.S.; Agnihotri S.; Thompson Y.Y.; Kuzan-Fischer C.M.; Farooq H.; Isaev K.; Daniels C.; Cho B.-K.; Kim S.-K.; Wang K.-C.; Lee J.Y.; Grajkowska W.A.; Perek-Polnik M.; Vasiljevic A.; Faure-Conter C.; Jouvet A.; Giannini C.; Nageswara Rao A.A.; Li K.K.W.; Ng H.-K.; Eberhart C.G.; Pollack I.F.; Hamilton R.L.; Gillespie G.Y.; Olson J.M.; Leary S.; Weiss W.A.; Lach B.; Chambless L.B.; Thompson R.C.; Cooper M.K.; Vibhakar R.; Hauser P.; van Veelen M.-L.C.; Kros J.M.; French P.J.; Ra Y.S.; Kumabe T.; Lopez-Aguilar E.; Zitterbart K.; Sterba J.; Finocchiaro G.; Massimino M.; Van Meir E.G.; Osuka S.; Shofuda T.; Klekner A.; Zollo M.; Leonard J.R.; Rubin J.B.; Jabado N.; Albrecht S.; Mora J.; Van Meter T.E.; Jung S.; Moore A.S.; Hallahan A.R.; Chan J.A.; Tirapelli D.P.C.; Carlotti C.G.; Fouladi M.; Pimentel J.; Faria C.C.; Saad A.G.; Massimi L.; Liau L.M.; Wheeler H.; Nakamura H.; Elbab, Intertumoral Heterogeneity within Medulloblastoma Subgroups, «CANCER CELL», 2017, 31, pp. 737 - 754.e6 [articolo]Open Access
Buckner, J.; Giannini, C.; Eckel-Passow, J.; Lachance, D.; Parney, I.; Laack, N.; Jenkins, R., Management of diffuse low-grade gliomas in adults - Use of molecular diagnostics, «NATURE REVIEWS. NEUROLOGY», 2017, 13, pp. 340 - 351 [articolo]
Brown, P. D.; Ballman, K. V.; Cerhan, J. H.; Anderson, S. K.; Carrero, X. W.; Whitton, A. C.; Greenspoon, J.; Parney, I. F.; Laack, N. N. I.; Ashman, J. B.; Bahary, J. -P.; Hadjipanayis, C. G.; Urbanic, J. J.; Barker, F. G.; Farace, E.; Khuntia, D.; Giannini, C.; Buckner, J. C.; Galanis, E.; Roberge, D., Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial, «THE LANCET ONCOLOGY», 2017, 18, pp. 1049 - 1060 [articolo]Open Access
Ida, C. M.; Butz, M. L.; Jenkins, R. B.; Sarkaria, J. N.; Kitange, G. J.; Giannini, C.; Kipp, B. R., Real-time methylation-specific polymerase chain reaction for MGMT promoter methylation clinical testing in glioblastoma an alternative detection method for a heterogeneous process, «AMERICAN JOURNAL OF CLINICAL PATHOLOGY», 2017, 148, pp. 296 - 307 [articolo]
Graffeo C.S.; Leeper H.E.; Perry A.; Uhm J.H.; Lachance D.J.; Brown P.D.; Ma D.J.; Van Gompel J.J.; Giannini C.; Johnson D.R.; Raghunathan A., Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma, «WORLD NEUROSURGERY», 2017, 103, pp. 655 - 663 [articolo]
Peacock, J. G.; Harmsen, W. S.; Link, M. J.; Van Gompel, J. J.; Giannini, C.; Olsen, K. D.; Garces, Y. I.; Neben Wittich, M. A.; Ma, D. J.; Park, S. S.; Foote, R. L., Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma, «JOURNAL OF NEUROLOGICAL SURGERY. PART B, SKULL BASE», 2017, 78, pp. 68 - 74 [articolo]
Vaubel, R. A.; Kollmeyer, T. M.; Caron, A. A.; Barr Fritcher, E. G.; Voss, J. S.; Liang, H.; Jenkins, R. B.; Giannini, C.; Kipp, B. R., Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism, «ACTA NEUROPATHOLOGICA», 2017, 134, pp. 317 - 319 [replica/breve intervento]
